Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III crossover comparison of KRP-108 vs fluticasone/salmeterol in pediatric bronchial asthma
jRCT2080223576Phase 3Completed
- Sponsor
- Kyorin Pharmaceutical
- Start
- Jun 2017
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of fluticasone propionate + formoterol in asthma (2 arms), sponsored by Kyorin Pharmaceutical. Primary endpoint: Mean peak expiratory flow (mPEF). Started Jun 2017; status: completed.
02
Drugs
fluticasone propionate + formoterol
03
Conditions
asthma
Beyond the preview
Go deeper on jRCT2080223576.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223576.